IC

Arcellx, Inc. (ACLX)

NASDAQ: ACLX · Real-Time Price · USD

59.50

+1.95 (3.39%)

At close: May 12, 2025, 4:00 PM

60.70

+1.20 (2.02%)

After-hours: May 12, 2025, 7:32 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cell Therapies	107.94M	Log In
Cell Therapies Growth	-2.16%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	107.94M	Log In
United States Growth	-2.16%	Log In